Who are we?

Aptus Clinical is a specialist UK-based Clinical Contract Research Organisation (CRO) with particular expertise in oncology, rare diseases and advanced, cell and gene therapies. We have decades of experience in delivering complex and innovative trials, transforming potential into value.

We are proud to be part of iMATCH, a Manchester-based consortium which is one of only three centres in the UK to be awarded funding by Innovate UK to coordinate scale-up of advanced therapies for a range of debilitating conditions.

In partnering with life science companies, we can help transform promising molecules into valued medicines. We ensure early clinical development strategies are optimised and that Phase I/II studies are both innovatively designed and expertly delivered.

Here is a brief potted history of how we got here: